Based on the assumption that circulating anti-SARS-CoV-2 IgG, generated during vaccination or infection, might cross-react with human Hsps, we hypothesized that volunteers who received the COVID-19 vaccine or had recovered from COVID-19 would show higher titers of anti-Hsp antibodies in their serum. Here, HSP90B2P is linked to infection.